Last reviewed · How we verify

NCT06373107

Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke

Terminated NA Last updated 11 July 2025
What this trial tests

NA trial testing High intensity gait training in Stroke in 3 participants. Terminated before completion.

Timeline
1 December 2024
Primary endpoint
30 May 2025
30 May 2025

Quick facts

Lead sponsorAlvernia University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment3
Start date1 December 2024
Primary completion30 May 2025
Estimated completion30 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Alvernia University

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvements in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of High intensity gait training

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Alvernia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06373107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing